In situ localization of Tau mRNA in developing rat brain

R. Takemura,Y. Kanai,N. Hirokawa

DOI: https://doi.org/10.1016/0306-4522(91)90064-U

IF: 3.708

1991-12-31

Neuroscience

Abstract:

What problem does this paper attempt to address?

Solid pseudopapillary tumor of the pancreas: a review of 553 cases in Chinese literature.

Peng-Fei Yu,Zhen-Hua Hu,Xin-Bao Wang,Jian-Min Guo,Xiang-Dong Cheng,Yun-Li Zhang,Qi Xu,Yu PF,Hu ZH

DOI: https://doi.org/10.3748/wjg.v16.i10.1209

IF: 5.374

2010-01-01

World Journal of Gastroenterology

Abstract:AIM: To sum up the clinical and pathological characteristics of solid pseudopapillary tumor (SPT) and the experience with it. METHODS: A total of 553 SPT patients reported in Chinese literature between January 1996 and January 2009 were retrospectively reviewed and analyzed. RESULTS: The mean age of the 553 SPT patients included in this review was 27.2 years, and the male to female ratio was 1:8.37. Their symptoms were nonspecific, and nearly one third of the patients were asymptomatic. Computed tomography and ultrasonography were performed to show the nature and location of SPT. Most of the tumors were distributed in the pancreatic head (39.8%), tail (24.1%), body and tail (19.5%). Forty-five patients (9.2%) were diagnosed as malignant SPT with metastasis or invasion. None of the clinical factors was closely related to the malignant potential of SPT. Surgery was the main therapeutic modality for SPT Local resection, distal pancreatectomy and pancreatoduodenectomy were the most common surgical procedures. Local recurrence and hepatic metastasis were found in 11 and 2 patients, respectively, after radical resection. Four patients died of tumor progression within 4 years after palliative resection of SPT The prognosis of SPT patients was good with a 5-year survival rate of 96.9%. CONCLUSION: SPT of the pancreas is a rare indolent neoplasm that typically occurs in young females. It is a low-grade malignancy and can be cured with extended resection. The prognosis of such patients is good although the tumor may recur and metastasize. (C) 2010 Baishideng. All rights reserved.
Computed Tomography and Magnetic Resonance Imaging Features of Solid Serous Cystadenomas of the Pancreas.

Jie-Yu Chen,Hai-Yan Chen,Yao Pan,Dan Shi,Ri-Sheng Yu

DOI: https://doi.org/10.3892/ol.2019.10346

2019-01-01

Oncology Letters

Abstract:Solid serous cystadenomas (SSC) of the pancreas are the rarest benign type of serous cystic neoplasms and are frequently misdiagnosed, resulting in unnecessary invasive surgical procedures. A retrospective study was performed to collect imaging features of SSC using computed tomography (CT) and magnetic resonance imaging. The clinical data and imaging study of 5 female patients with pathologically confirmed SSC (mean age, 44.2 years; range, 23-69 years) diagnosed between January 2006 and July 2017 were retrospectively analyzed. The imaging study was assessed by two experienced radiologists in consensus. All patients had tumors with a mean size of 2.3 cm (range, 1.5-3.2 cm; 4/5 lesions ≤3 cm). The tumors were located in the tail of pancreas in 3 cases and in the neck of the pancreas in 2 cases. The tumors were all well defined, with an ovoid and lobulated shape and fibrous capsules. Consequently, they presented as low density on unenhanced CT images, marked hyperintensity on T2-weighted images in 4 cases and slight hyperintensity in 1 case. However, they exhibited heterogeneous wash-in and wash-out enhancement in 2 cases and moderate and prolonged enhancement in 3 cases. The apparent diffusion coefficient (ADC) values of the lesions were >2×10-3 mm2/sec. Therefore, a small tumor size, signal intensity on T2-weighted images, high ADC values, fibrous capsules and enhancement patterns may be indicative imaging features of SSCs.
Heterotopic Accessory Spleen with Squamous Epithelial Cyst in Pancreas Mimicking Other Pancreatic Tumor: a Case Report

Jieli Luo,Jianshe Chen,Fengbo Huang,Panpan Zhou,Pintong Huang

DOI: https://doi.org/10.21037/atm.2020.03.79

IF: 3.616

2020-01-01

Annals of Translational Medicine

Abstract:A 49-year-old female undergoing a periodic health examination at other hospital revealed a mass in the tail of pancreas. The patient denied any personal history of surgery except subtotal hysterectomy because of multiple myomas in uterus 7 years ago, family history of abdominal cancer and trauma. Physical examination and laboratory finding (including tumor marker) were unremarkable. Chest X-ray result was normal. Contrast enhanced ultrasound (CEUS) examination showed a well-defined hypoechoic pancreatic mass which was suggestive of solid pseudopapillary tumor. Contrast enhanced computed tomography (CE-CT) of the abdomen revealed a mass of hypodensity suggestive of intraductal papillary mucinous neoplasm. Because of the risk of bleeding and exclusion of surgical contraindications, patient underwent laparoscopic surgery. Intraoperatively, a solid mass was identified in the tail of pancreas, the intraoperative frozen pathological examination suggested a heterotopic accessary spleen (HAS) with squamous epithelial cyst. Partial pancreatectomy was performed. The uniqueness of this case is that the spleen can be ectopic to the pancreas, what is even more unexpected is that the HAS undergone cystic change. When encountering a pancreatic mass, we need to think about the possibility of HAS. In conclusion, it is important to diagnose HAS with squamous cyst in the pancreatic tail presenting as other pancreatic masses.
Management of Primary Squamous Cell Carcinoma of the Pancreas: A Case Report.

Danling Guo,Chao Chen,Sangying Lv,Guanzuan Wu,Wei Shi,Huaifeng Li,Hongjie Hu

DOI: https://doi.org/10.3389/fsurg.2021.700229

IF: 1.8

2021-01-01

Frontiers in Surgery

Abstract:Introduction: Primary squamous cell carcinoma of the pancreas (SCCP) is a rare malignant tumor that has been reported in individual case reports only. The clinical data on primary SCCP treatment are limited. Therefore, the appropriate management strategy for this disease should be standardized. Case Presentation: We present the case of a 63-year-old man admitted to our hospital for upper left abdominal pain for 2 months without weight loss or jaundice. Enhanced computed tomography (CT) and magnetic resonance imaging (MRI) of the abdomen revealed a mixed solid and cystic lesion in the pancreatic tail, measuring 35 × 37 mm in maximum diameter with enhancement. The patient was diagnosed with primary SCCP without metastasis, based on radiological and pathological findings. He did not receive neoadjuvant therapy postoperatively and was followed up by CT and MRI for 18 months without recurrence or metastasis. Result: Complete resection is the most effective treatment for early stage primary SCCP. Abdominal MRI is an effective imaging tool for preoperative evaluation and postoperative follow-up of primary SCCP. The need for neoadjuvant therapy depends on various factors. Conclusion: Primary SCCP is a tumor with poor prognosis. Risk factor control, early accurate radiologic evaluation, and individualized treatment strategies improve the quality of life and prolong the overall survival period of patients.
Solid Pseudopapillary Tumors of the Pancreas: Diagnosis and Treatment

WU Jun-li,QIAN Zhu-yin,DAI Cun-cai,XU Ze-kuan,JIANG Kui-rong,LI Qiang,GAO Wen-tao,GUO Feng,CHEN Jian-min,WEI Ji-shu,MIAO Yi

DOI: https://doi.org/10.3760/cma.j.issn.1674-1935.2009.04.010

2009-01-01

Abstract:Objective To summarize the experience in the diagnosis and treatment of solid pseudopapillary tumors of the pancreas. Methods Ten consecutive patients who underwent surgery with pathologically confirmed solid pseudopapillary tumors of the pancreas between October 2005 and December 2008 were retrospectively reviewed. Results All of the 10 patients were female and the median age at diagnosis was 24 years (range, 11 -39 years). Abdominal discomfort or pain were the most common presenting symptoms. 4 patients had palpable abdominal mass at physical examination. The tumors appeared on ultrasonography and/or CT, MRI as solid or cystic masses. The preoperative serum biochemical parameters and tumor markers level were within the normal range. All the patients underwent surgical treatment. The tumors were located in the head/neck (n = 6) or the distal part (n = 4) of the pancreas. The surgical procedures included enucleation (n=3) , distal pancreatectomy (n=3 , two with preservation of the spleen, one combined with splenectomy, distal gastrectomy and partial colectomy) , segmental pancreatectomy with pancreaticojejunostomy (n=3) and pancreaticoduodenectomy (n = 1). Pancreatic fistula (n = 2) was observed postoperatively and resolved with conservative treatment. The median resected tumor size was 5. 9 cm. All patients were alive and remained recurrence and metastasis free after a median followk-up of 19. 2 months (range, 8～42 months). Conclusions Solid pseudopapillary tumor of the pancreas was rare neoplasm occurred predominantly in young women with low malignant potential. Aggressive resection should be attempted and could result in excellent prognosis.
Diagnosis and Treatment of Solid-Pseudopapillary Tumor of the Pancreas.

Hao Zhang,Ting-Bo Liang,Wei-Lin Wang,Yan Shen,Guo-Ping Ren,Shu-Sen Zheng

2006-01-01

Abstract:BACKGROUND:Solid-pseudopapillary tumor (SPT) of the pancreas is a rare exocrine pancreatic tumor. Despite the increasing recognition of the tumor in recent years, its pathogenesis and apparent therapeutic algorithm remain unclear. This study was designed to define the clinical, imaging, and pathologic features and to improve the diagnosis and treatment of this rare disease.METHOD:The clinical, imaging, and pathologic findings of 9 SPT patients managed in our hospital between 2001 and 2005 were retrospectively analyzed, and related literatures were reviewed.RESULTS:In the 9 patients aged from 14 to 68 years, 8 were female and 1 male. The mean age of these patients at diagnosis was 30 years. Initially, 8 patients complained of vague abdominal pain and one patient had pancreatic mass detected incidentally by abdominal CT. The levels of blood and urine amylase and tumor markers were all within the normal range. B-US, CT and MRI demonstrated that tumors were well encapsulated and contained some degree of internal hemorrhage or cystic degeneration. The mean transverse diameter of these tumors was 5.4 cm (range, 2-10.5 cm). The tumors were located at the head (2 patients), body (2), body and tail junction (4), and tail (1) of the pancreas. Surgical procedures included pancreaticoduodenectomy, distal pancreatectomy, distal pancreatectomy with splenectomy, and enucleation. Histological examination showed solidified cystic areas and papillary protrusions. Two malignant tumors demonstrated retroperitoneal metastases and vascular invasion. Follow-up for 2.5 years on average showed that one patient died of tumor recurrence at 10 months and the rest were alive.CONCLUSIONS:SPT exhibits unique clinical and pathologic features and is readily diagnosed by its characteristic imaging and histological appearance. Surgical resection of the primary tumor and metastases is the treatment of choice.
Rare tumours of the pancreas: monocentric study

Astrid Bauschke,Annelore Altendorf-Hofmann,Aladdin Ali-Deeb,Michael Ardelt,Felix Dondorf,Falk Rauchfuss,Oliver Rohland,Aysun Tekbaș,Utz Settmacher

DOI: https://doi.org/10.1007/s00432-024-05884-2

2024-07-14

Journal of Cancer Research and Clinical Oncology

Abstract:The biology of rare pancreatic tumours, which differs from that of ductal pancreatic cancer, requires increased attention. Although the majority of rare pancreatic tumours are benign, it is difficult to decide whether an invasive component exists without complete removal of the lesion, despite considerable progress in diagnosis. We are investigating a large cohort of patients with histologically confirmed epithelial non-ductal non-neuroendocrine neoplasms of the pancreas.

oncology
Differential Diagnosis of Small Solid Pancreatic Lesions.

Christoph Frank Dietrich,Anand Vasante Sahai,Mirko D’Onofrio,Uwe Will,Paolo Giorgio Arcidiacono,Maria Chiara Petrone,Michael Hocke,Barbara Braden,Eike Burmester,Kathleen Möller,Adrian Săftoiu,Andre Ignee,Xin-Wu Cui,Sevastita Iordache,Andrej Potthoff,Julio Iglesias-Garcia,Pietro Fusaroli,Yi Dong,Christian Jenssen

DOI: https://doi.org/10.1016/j.gie.2016.04.034

IF: 10.396

2016-01-01

Gastrointestinal Endoscopy

Abstract:BACKGROUND AND AIMS:Pancreatic ductal adenocarcinoma (PDAC) is typically diagnosed at a late stage. Little is known about the incidental finding of early-stage PDAC. The aim of the current study was to determine the etiology of small solid pancreatic lesions (≤15 mm) to optimize clinical management.METHODS:Inclusion criterion for the retrospective study analysis was the incidental finding of primarily undetermined small solid pancreatic lesions ≤15 mm in 394 asymptomatic patients. Final diagnoses were based on histology or cytology obtained by imaging-guided biopsy (and at least 12-month follow-up) and/or surgery. Contrast-enhanced US or contrast-enhanced EUS was performed in 219 patients.RESULTS:The final diagnoses of 394 patients were as follows: 146 PDACs, 156 neuroendocrine tumors, 28 metastases into the pancreas from other primary sites, and 64 various other etiologies. Contrast-enhanced US allowed differential diagnosis of PDAC and non-PDAC in 189 of 219 patients (86%).CONCLUSIONS:Approximately 40% of patients with small solid pancreatic lesions had very early stage PDAC. Approximately 60% of small solid pancreatic lesions ≤15 mm are not PDAC and, therefore, do not require radical surgery. Without preoperative diagnosis, an unacceptably large proportion of patients would be exposed to radical surgery with significant morbidity and mortality.
Solid-pseudopapillary tumor of pancreas: diagnosis and treatment

WEN Quan,QIAO Qi-lu,LIU Zhan-bing,ZHAO Jian-xun,LIU Yu-cun

2008-01-01

Abstract:[Objective] To investigate clinicopathological features and treatment of solid-pseudopapillary tumors of pancreas. [Methods] A serie of 15 patients admitted from 2004 to 2007 with solid-pseudopapillary tumors of pancreas were retrospectively reviewed. [Results] Mean age of the 15 patients was (30.1±13.9) years (range from 10~71). Including 1 man and 14 women. The lesions were located in the head of pancreas in 5 patients,in the body and neck in 5, and in the tail in 5. Surgical procedures included pancreaticoduodenectomies in 3 patients, simple enucleation in 5, distal pancreatectomy with splenectomy in 6, and 1 laparoscopic distal pancreatectomy. The mean tumor size was (6.5±3.2) cm. Pancreatic fistula occurred in 1 patient. The mean follow-up period was 32 months, and all patients were alive. [Conclusion] Solid-pseudopapillary tumor of pancreas was a kind of rare tumor with low malignant potential that predominantly found in young women. Favorable prognosis may achieve after complete surgical excision.
Solid Pseudopapillary Tumor of the Pancreas: a Case Series of 26 Consecutive Patients

Feng Yang,Chen Jin,Jiang Long,Xian Jun Yu,Jin Xu,Yang Di,Ji Li,De Liang Fu,Quan Xing Ni

DOI: https://doi.org/10.1016/j.amjsurg.2008.07.062

2009-01-01

Abstract:OBJECTIVE: Solid pseudopapillary tumor (SPT) of the pancreas, which predominantly affects young women, is a relatively indolent entity with favorable prognosis. The aim of this study is to describe the clinicopathologic features and surgical management of this disease in our institution.METHODS: A retrospective study of clinical data from 26 consecutive patients with SPT managed in a tertiary academic center between January 2002 and December 2007 was performed. Clinicopathologic factors were compared between benign and malignant cases to determine what features of the tumor could suggest malignant potential.RESULTS: The 26 cases included 22 female and 4 male patients, and the average age was 32.3 years (range 15 to 64). Clinical symptoms were nonspecific and included upper abdominal pain or discomfort, abdominal distention, and back pain. The neoplasm was localized in the pancreatic head/neck in 14 patients and in the body/tail in 12 patients. The median diameter of these lesions was 6.25 cm (range 2 to 15). All of the tumors-including 8 pancreaticoduodenectomies, 10 distal pancreatectomies, 6 local resections, 1 total pancreatectomy, and 1 central pancreatectomy-were resected successfully. No patient received chemotherapy or radiotherapy after surgery. All of the patients except 1 were alive at a median follow-up of 32.5 months (range 3 to 69). One of the 2 patients with malignant SPT, in whom Ki-67 immunoreactivity was >25%, developed local recurrence with liver metastasis 4 months and died 6 months after surgery. There were no significant associations between clinicopathologic factors and malignancy.CONCLUSIONS: SPT is a rare neoplasm with low malignant potential. Characteristic computed axial tomography and magnetic resonance imaging scans combined with age and sex profile should be sufficient for the decision to operate. Patients with malignant SPT should have careful follow-up. The high proliferative index assessed by immunohistochemical staining for Ki-67 may predict poor outcome of malignant SPT. Crown Copyright (c) 2009 Published by Elsevier Inc. All rights reserved.
Sarcomatoid Carcinoma of the Pancreas: A Case Report

Dong-Kai Zhou,Bing-Qiang Gao,Wang Zhang,Xiao-Hui Qian,Li-Xiong Ying,Wei-Lin Wang

DOI: https://doi.org/10.12998/wjcc.v7.i2.236

2019-01-01

World Journal of Clinical Cases

Abstract:BACKGROUND Sarcomatoid carcinoma of the pancreas (SCP) is a rare and aggressive epithelial tumor that has both epithelial and mesenchymal features. It is characterized by sarcomatous elements with evidence of epithelial differentiation. And the term “sarcomatoid carcinoma” is often confused with “carcinosarcoma”. CASE SUMMARY We present a case of SCP with lymph node metastasis in a 59-year-old male patient. He had experienced darkening of the urine, scleral icterus, and fatigue for 4 weeks. Computed tomography and magnetic resonance imaging revealed a mass in the pancreatic head, and laboratory tests revealed elevated serum bilirubin levels. The patient underwent pancreaticoduodenectomy after biliary decompression. Histologically, spindle cells with marked nuclear atypia and brisk mitotic activity arranged in a storiform or fascicular pattern were present in the bulk of the tumor. Immunohistochemical analysis found that the spindle cells exhibited strong diffuse positivity for epithelial markers, indicative of epithelial differentiation. Accordingly, the pathologic diagnosis of the pancreatic neoplasm was SCP. CONCLUSION Although sarcomatoid carcinomas and carcinosarcomas have different pathologic features, both have epithelial origin.
Surgical Treatment of Solid Pseudopapillary Neoplasm

Xiang-feng GUO,Yan-lian ZHANG,Jian-jun LENG

DOI: https://doi.org/10.15912/j.cnki.gocm.2016.24.017

2016-01-01

Abstract:Objecttive To study clinical features, diagnosis and surgical treatment of the solid pseudopaillary tumor of the pancreas.Methods The clinical data of 12 surgically treated patients with SPTP were retrospective analyzed.Results There were 3males and 9 females, median age 36.5years. Surgical procedures were performed including pancreaticoduodenectomy in 1 patient,tumors enucleated within capsule in 7,one patients via Iaparoscopy.Conclusion Solid pseudopapillary tumor of pancreas was one of rare pancreatic neoplasms with low malignant potential, predominantly found in young women . According to the tumor capsule, and common bile duct, pancreatic duct relations, choose different ways of operation. Surgical resection results in a long-term survival.
Enantioselective analysis of zopiclone in rat brain by liquid chromatography tandem mass spectrometry

Milena Araújo Tonon,V. A. P. Jabor,P. S. Bonato

DOI: https://doi.org/10.1007/s00216-012-6487-4

Analytical and Bioanalytical Chemistry

Abstract:
[The use of the alcian-PAS-cresyl violet technic in the study of granular cells of the connective tissue in rats].

C. Catini

1969-07-01

Abstract:
Nonepithelial Neoplasms of the Pancreas, Part 2: Malignant Tumors and Tumors of Uncertain Malignant Potential From the Radiologic Pathology Archives

Maria A Manning,Edina E Paal,Amogh Srivastava,Koenraad J Mortele

DOI: https://doi.org/10.1148/rg.2018170201

Radiographics

Abstract:Almost all neoplasms of the pancreas are derived from pancreatic epithelial components, including the most common pancreatic mass, primary pancreatic ductal adenocarcinoma (PDAC). Nonepithelial neoplasms comprise only 1%-2% of all pancreatic neoplasms. Although some may arise directly from intrapancreatic elements, many originate from mesenchymal, hematopoietic, or neural elements in the retroperitoneal peripancreatic space and grow into the pancreas. Once these tumors reach a certain size, it can be challenging to identify their origin. Because these manifest at imaging as intrapancreatic masses, awareness of the existence and characteristic features of these nonepithelial neoplasms is crucial for the practicing radiologist in differentiating these tumors from primary epithelial pancreatic tumors, an important distinction given the vastly different management and prognosis. In part 1 of this article, the authors reviewed benign nonepithelial neoplasms of the pancreas. This article focuses on malignant nonepithelial neoplasms and those of uncertain malignant potential that can be seen in the pancreas. The most common malignant or potentially malignant nonepithelial pancreatic tumors are of mesenchymal origin and include soft-tissue sarcomas, solitary fibrous tumor, and inflammatory myofibroblastic tumor. These tumors commonly manifest as large heterogeneous masses, often containing areas of necrosis and hemorrhage. The clinical features associated with these tumors and the imaging characteristics including enhancement patterns and the presence of fat or calcification help distinguish these tumors from PDAC. Hematopoietic tumors, including lymphoma and extramedullary plasmacytoma, can manifest as isolated pancreatic involvement or secondarily involve the pancreas as widespread disease. Hyperenhancing paragangliomas or hypervascular metastatic disease can mimic primary pancreatic neuroendocrine tumors or vascular anomalies.
Hemolymphangioma: A Rare Differential Diagnosis of Cystic-Solid or Cystic Tumors of the Pancreas

Fei Dong,Yi Zheng,Jian-Jun Wu,Yan-Biao Fu,Kai Jin,Ming Chao

DOI: https://doi.org/10.3748/wjg.v19.i22.3520

IF: 5.374

2013-01-01

World Journal of Gastroenterology

Abstract:We report a case of pancreatic hemolymphangioma. Hemolymphangioma is a malformation of both lymphatic vessels and blood vessels. The incidence of this disease in the pancreas is extremely rare. To the best of our knowledge, only seven cases have been reported worldwide (PubMed). A 39-year-old woman with a oneday history of abdominal pain was admitted to our hospital. There was no obvious precipitating factor. The preoperative examination, including ultrasonography and computed tomography, showed a cystic-solid tumor in the pancreas, and it was considered to be a mucinous cystadenoma or cystadenocarcinoma. Pancreaticbody-tail resection combined with splenectomy was performed. After the operation, the tumor was pathologically demonstrated to be a pancreatic hemolymphangioma. Although pancreatic hemolymphangioma is rare, we believe that it should be considered in the differential diagnosis of cystic-solid tumors of the pancreas, particularly when there is no sufficient evidence for diagnosing cystadenoma, cystadenocarcinoma or some other relatively common disease of the pancreas.
Stability of different formulations and ion pairs of hypericin.

A. Huygens,A. Kamuhabwa,P. D. de Witte

DOI: https://doi.org/10.1016/J.EJPB.2004.09.014

IF: 5.589

2005-04-01

European Journal of Pharmaceutics and Biopharmaceutics

Abstract:
[The Diagnosis and Treatment of Solid-Pseudopapillary Tumor of Pancreas].

Yu-pei Zhao,Ya Hu,Quan Liao,Meng-hua Dai,Wei-wei Wu,Li-xing Cai,Yu Zhu

DOI: https://doi.org/10.3760/j:issn:0529-5815.2005.01.016

2005-01-01

Abstract:OBJECTIVE:To summarize the experience of diagnosis and treatment in solid-pseudopapillary tumor of pancreas (SPT).METHOD:Retrospectively analyzed 12 cases of SPT diagnosed between 2000 August and 2004 February in Peking Union Medical College Hospital.RESULTS:The average age of these 12 cases was 29.1, including 11 women and 1 men. The tumors of 6 cases were located in the pancreatic head, one tumor was in the neck of pancreas and 5 tumors were in the body and tail of pancreas. There were no characteristic clinical manifestations. Solid and solid-cystic masses of low echo were found in pancreas in ultrasonic examinations. CT scan found masses of low density in pancreas, while irregular enhancement appeared in the circumference of all tumors in enhanced CT scan sequences. Tumor markers in patients' serum were all negative. Pancreaticoduodenectomy were performed in 2 cases. Resection of tumors and pancreaticojejunostomy were performed in 3 cases. Simple resection of tumor was performed in 1 case. Segmental pancreatectomy and pancreaticojejunostomy was performed in one patient. Five patients underwent distal pancreatectomy and spleen resection. Ten patients were followed up with the average time of 14.3 months. No evidence of relapses and metastasis in these cases was found.CONCLUSION:Solid-pseudopapillary tumor of pancreas was one of rare pancreatic neoplasm with low malignant potential, affecting primarily young women. Complete resection resulted in long-term survival.
Diagnostic Pearls and Pitfalls in the Evaluation of Biopsies of the Pancreas

Claudio Luchini

DOI: https://doi.org/10.5858/arpa.2023-0426-ra

2024-02-23

Archives of Pathology & Laboratory Medicine

Abstract:Context.— The examination of small pancreatic biopsies is a difficult task for pathologists. This is due to the scant and fragmented material often obtained from diagnostic procedures as well as the significant overlap between different neoplastic and nonneoplastic entities. In the upcoming neoadjuvant era, biopsies could become even more important, representing the only possibility to look at the real histomorphology of tumors before chemotherapy-induced modifications. Objectives.— To summarize and discuss the state-of-the-art diagnostic workflow for small pancreatic biopsies, including the most important morphologic and immunohistochemical features and molecular alterations. The main diagnostic pearls and pitfalls of this challenging scenario are also discussed. The most important topics of this review are represented by: (1) pancreatic ductal adenocarcinoma, along with its main differential diagnoses, including autoimmune pancreatitis; (2) solid hypercellular neoplasms, including neuroendocrine neoplasms, acinar cell carcinoma, pancreatoblastoma, and solid pseudopapillary neoplasms; and (3) cystic lesions. Real-world considerations will be also presented and discussed. Data Sources.— Sources included a literature review of published studies and the author’s own work. Conclusions.— The correct diagnosis of pancreatic lesions is a crucial step in the therapeutic journey of patients. It should be based on robust, standardized, and reliable hallmarks. As presented and discussed here, the integration of morphology with immunohistochemistry, and in selected cases, with molecular analysis, represents a decisive step in this complex scenario.

pathology,medical laboratory technology,medicine, research & experimental
Robotic left pancreatectomy for pancreatic solid pseudopapillary tumor

Dimitrios Ntourakis,Ettore Marzano,Vito De Blasi,Elie Oussoultzoglou,Daniel Jaeck,Patrick Pessaux

DOI: https://doi.org/10.1245/s10434-010-1376-6

Abstract:Background: Solid pseudopapillary pancreatic tumors of pancreas are a rare entity, seen most often in females in their second or third decades. Although previously believed to be benign, this tumor is currently considered a low-grade malignant epithelial neoplasm with low metastatic rate and high overall survival.1,2 Its resection could be performed by robotic technique with respect to oncological principles to avoid tumor cell dissemination.3 Methods: In this multimedia article, we present a 28-year-old female with a history of hyperthyroidism who underwent a computed tomography (CT) scan because of a persistent high C-reactive protein level following caesarean section. This CT scan revealed a 7-cm cystic lesion of the pancreatic tail. The serum tumor marker CA 19-9 was normal. Further investigation with an magnetic resonance imaging (MRI) scan showed that the lesion was macrocystic with internal septas compatible with a solid pseudopapillary neoplasm.4 The patient was treated with robotic distal splenopanceatectomy (video). Results: The operative time was 5 h with an estimated blood loss of 250 mL. No blood transfusion was necessary. The postoperative period was uneventful, and she was discharged on postoperative day 8. The histological finding revealed a solid pseudopapillary tumor of the pancreas pT2pN0 (0/14 lymph nodes removed). There was no evidence of clinical, biological, and radiological pancreatic fistula, and a control CT scan on postoperative day 8 did not show any abdominal fluid collection. The patient's 1 month follow-up was normal. Discussion: The robotic distal splenopancreatectomy is a procedure that offers some technical and oncological advantages over the already described minimally invasive techniques for distal pancreatic tumors.5,6 These advantages are mainly due to the stability of the operative field, to the 3D and magnified vision, and to the articulated robotic arms.7-9 The 3D representation and the stability of the operative field facilitate the performance of operative steps, as the creation of the retropancreatic tunnel and vascular identification. Moreover, the robotic articulated arms permit a superior handling of vascular structures, allowing a fine dissection that is extremely useful during lymphadenectomy. Articulated instruments easily achieve the correct rotation axis, thus minimizing peri-pancreatic tissue retraction and manipulation of the pancreatic gland. This smooth and no-touch technique in theory minimizes the risk of pancreatic capsule rupture as well as tumor cell dissemination, respecting oncological surgical standards. However, robotic surgery needs an adequate learning curve, especially concerning the installation and the lack of force feedback. Conclusion: The robotic distal pancreatectomy is a possible minimally invasive technique for patients with solid pseudopapillary pancreatic tumors. It presents some advantages over the laparoscopic approach. Nevertheless its oncological indications are yet to be defined.10.

In situ localization of Tau mRNA in developing rat brain

Solid pseudopapillary tumor of the pancreas: a review of 553 cases in Chinese literature.

Computed Tomography and Magnetic Resonance Imaging Features of Solid Serous Cystadenomas of the Pancreas.

Heterotopic Accessory Spleen with Squamous Epithelial Cyst in Pancreas Mimicking Other Pancreatic Tumor: a Case Report

Management of Primary Squamous Cell Carcinoma of the Pancreas: A Case Report.

Solid Pseudopapillary Tumors of the Pancreas: Diagnosis and Treatment

Diagnosis and Treatment of Solid-Pseudopapillary Tumor of the Pancreas.

Rare tumours of the pancreas: monocentric study

Differential Diagnosis of Small Solid Pancreatic Lesions.

Solid-pseudopapillary tumor of pancreas: diagnosis and treatment

Solid Pseudopapillary Tumor of the Pancreas: a Case Series of 26 Consecutive Patients

Sarcomatoid Carcinoma of the Pancreas: A Case Report

Surgical Treatment of Solid Pseudopapillary Neoplasm

Enantioselective analysis of zopiclone in rat brain by liquid chromatography tandem mass spectrometry

[The use of the alcian-PAS-cresyl violet technic in the study of granular cells of the connective tissue in rats].

Nonepithelial Neoplasms of the Pancreas, Part 2: Malignant Tumors and Tumors of Uncertain Malignant Potential From the Radiologic Pathology Archives

Hemolymphangioma: A Rare Differential Diagnosis of Cystic-Solid or Cystic Tumors of the Pancreas

Stability of different formulations and ion pairs of hypericin.

[The Diagnosis and Treatment of Solid-Pseudopapillary Tumor of Pancreas].

Diagnostic Pearls and Pitfalls in the Evaluation of Biopsies of the Pancreas

Robotic left pancreatectomy for pancreatic solid pseudopapillary tumor